Cui-Zan Cai

1.3k total citations
17 papers, 712 citations indexed

About

Cui-Zan Cai is a scholar working on Epidemiology, Neurology and Pharmacology. According to data from OpenAlex, Cui-Zan Cai has authored 17 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Neurology and 5 papers in Pharmacology. Recurrent topics in Cui-Zan Cai's work include Autophagy in Disease and Therapy (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Alzheimer's disease research and treatments (4 papers). Cui-Zan Cai is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Alzheimer's disease research and treatments (4 papers). Cui-Zan Cai collaborates with scholars based in Macao, China and Hong Kong. Cui-Zan Cai's co-authors include Jiahong Lu, Mingyue Wu, Min Li, Huanxing Su, Jieqiong Tan, Ningning Yuan, Ju‐Xian Song, Min Li, Xu‐Xu Zhuang and Qi Zhu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Applied Microbiology and Biotechnology.

In The Last Decade

Cui-Zan Cai

17 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cui-Zan Cai Macao 16 270 257 156 155 128 17 712
Mingyue Wu China 21 382 1.4× 326 1.3× 173 1.1× 224 1.4× 145 1.1× 47 1.1k
Weijin Liu China 11 339 1.3× 191 0.7× 116 0.7× 38 0.2× 206 1.6× 21 684
Adolfo Garcia Erustes Brazil 10 186 0.7× 117 0.5× 128 0.8× 63 0.4× 97 0.8× 20 498
Nikolaos Georgakopoulos United Kingdom 12 462 1.7× 267 1.0× 106 0.7× 55 0.4× 82 0.6× 19 844
Tz‐Chuen Ju Taiwan 16 511 1.9× 88 0.3× 137 0.9× 54 0.3× 135 1.1× 25 845
Myung‐Hee Moon South Korea 13 370 1.4× 157 0.6× 155 1.0× 37 0.2× 44 0.3× 18 610
Ji‐Hong Moon South Korea 18 343 1.3× 213 0.8× 109 0.7× 77 0.5× 23 0.2× 34 665
Jeong Seon Yoon South Korea 18 547 2.0× 115 0.4× 85 0.5× 117 0.8× 98 0.8× 28 997

Countries citing papers authored by Cui-Zan Cai

Since Specialization
Citations

This map shows the geographic impact of Cui-Zan Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui-Zan Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui-Zan Cai more than expected).

Fields of papers citing papers by Cui-Zan Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cui-Zan Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui-Zan Cai. The network helps show where Cui-Zan Cai may publish in the future.

Co-authorship network of co-authors of Cui-Zan Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Cui-Zan Cai. A scholar is included among the top collaborators of Cui-Zan Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui-Zan Cai. Cui-Zan Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Jiayue, Qi Zhu, Cui-Zan Cai, Hai‐Bin Luo, & Jiahong Lu. (2022). α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation. Phytomedicine. 101. 154125–154125. 13 indexed citations
2.
Cai, Cui-Zan, Xu‐Xu Zhuang, Qi Zhu, et al.. (2022). Enhancing autophagy maturation with CCZ1-MON1A complex alleviates neuropathology and memory defects in Alzheimer disease models. Theranostics. 12(4). 1738–1755. 23 indexed citations
3.
Zhu, Qi, Xu‐Xu Zhuang, Jiayue Chen, et al.. (2021). Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models. Phytomedicine. 87. 153578–153578. 23 indexed citations
4.
Chong, Cheong‐Meng, Qi Zhu, Ke Zhang, et al.. (2021). Comprehensive Perspectives on Experimental Models for Parkinson’s Disease. Aging and Disease. 12(1). 223–223. 29 indexed citations
5.
Cai, Cui-Zan, Chuanbin Yang, Xu‐Xu Zhuang, et al.. (2020). NRBF2 is a RAB7 effector required for autophagosome maturation and mediates the association of APP-CTFs with active form of RAB7 for degradation. Autophagy. 17(5). 1112–1130. 34 indexed citations
6.
Wu, Mingyue, Le Liu, Haitao Xiao, et al.. (2020). PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation. Autophagy. 17(5). 1096–1111. 65 indexed citations
7.
Zhuang, Xu‐Xu, Yuan Tan, Ju‐Xian Song, et al.. (2020). Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson’s disease models. Cell Death and Disease. 11(2). 128–128. 99 indexed citations
8.
Cai, Cui-Zan, Hefeng Zhou, Ningning Yuan, et al.. (2019). Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation. Phytomedicine. 61. 152842–152842. 37 indexed citations
9.
Yuan, Ningning, Cui-Zan Cai, Mingyue Wu, et al.. (2019). Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology. Frontiers in Pharmacology. 10. 16–16. 21 indexed citations
10.
Yuan, Ningning, Cui-Zan Cai, Mingyue Wu, et al.. (2019). Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies. BMC Complementary and Alternative Medicine. 19(1). 109–109. 93 indexed citations
11.
Wu, Mingyue, et al.. (2017). Selective autophagy: The new player in the fight against neurodegenerative diseases?. Brain Research Bulletin. 137. 79–90. 20 indexed citations
12.
Liu, Liang‐Feng, Mingyue Wu, Cui-Zan Cai, et al.. (2017). Baicalein prevents 6-OHDA/ascorbic acid-induced calcium-dependent dopaminergic neuronal cell death. Scientific Reports. 7(1). 8398–8398. 23 indexed citations
13.
Wu, Mingyue, Cui-Zan Cai, Jieqiong Tan, et al.. (2017). Natural autophagy blockers, dauricine (DAC) and daurisoline (DAS), sensitize cancer cells to camptothecin-induced toxicity. Oncotarget. 8(44). 77673–77684. 37 indexed citations
14.
Yang, Chuanbin, Cui-Zan Cai, Ju‐Xian Song, et al.. (2017). NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models. Autophagy. 13(12). 2028–2040. 59 indexed citations
15.
Wu, Mingyue, et al.. (2016). Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. Journal of Ethnopharmacology. 194. 861–876. 71 indexed citations
16.
Cai, Cui-Zan, Xiaoyong Dai, Yujie Zhu, et al.. (2015). A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder. Applied Microbiology and Biotechnology. 100(2). 825–835. 37 indexed citations
17.
Dai, Xiaoyong, Cui-Zan Cai, Fei Xiao, et al.. (2014). Identification of a novel aFGF-binding peptide with anti-tumor effect on breast cancer from phage display library. Biochemical and Biophysical Research Communications. 445(4). 795–801. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026